According to et al., applying wogonin and TRAIL in a mouse model of lung cancer enhances TRAIL’s antitumor activity and overcomes MDR through augmentation of apoptosis and decreased the expression of anti-apoptotic proteins (survivin, XIAP, etc.)[41]. The gene discussed is TNFSF10; the disease is lung carcinoma.